Halsa Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Halsa Pharma
Halsa Pharma Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2003 and has a history of 21 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Purohit, Sadhana Damani, and Kailashchandra Purohit serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2003PTC138991
-
Company No.
138991
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Halsa Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Purohit
|
Director | 16-May-2019 | Current |
|
Sadhana Damani
|
Director | 16-May-2019 | Current |
|
Kailashchandra Purohit
|
Director | 30-Jan-2019 | Current |
Financial Performance of Halsa Pharma.
Halsa Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Halsa Pharma?
In 2017, Halsa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lollapalooza Enterprises LlpMahesh Purohit is a mutual person
-
Stenos Developers Private Limited
Mahesh Purohit is a mutual person
-
H J Realtech Private Limited
Mahesh Purohit is a mutual person
-
H J Securities Private Limited
Mahesh Purohit is a mutual person
-
Burflower Realty And Agroventures Private Limited
Sadhana Damani is a mutual person
-
Shubhchintak Properties Private Limited
Sadhana Damani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Halsa Pharma?
Unlock and access historical data on people associated with Halsa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Halsa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halsa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
